These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31921109)

  • 21. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic Reprogramming Entangles with Hematopoiesis.
    Wei C; Yu P; Cheng L
    Trends Cell Biol; 2020 Oct; 30(10):752-763. PubMed ID: 32861580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of transcription factor mediated cell reprogramming: conversion of liver to pancreas.
    Wild SL; Tosh D
    Biochem Soc Trans; 2021 Apr; 49(2):579-590. PubMed ID: 33666218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprogramming antitumor immunity.
    Crompton JG; Clever D; Vizcardo R; Rao M; Restifo NP
    Trends Immunol; 2014 Apr; 35(4):178-85. PubMed ID: 24661777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise review: harmonies played by microRNAs in cell fate reprogramming.
    Moradi S; Asgari S; Baharvand H
    Stem Cells; 2014 Jan; 32(1):3-15. PubMed ID: 24155164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in the reprogramming of somatic cells.
    Ma T; Xie M; Laurent T; Ding S
    Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
    Sanges D; Lluis F; Cosma MP
    Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming: identifying the mechanisms that safeguard cell identity.
    Brumbaugh J; Di Stefano B; Hochedlinger K
    Development; 2019 Dec; 146(23):. PubMed ID: 31792064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards understanding transcriptional networks in cellular reprogramming.
    Firas J; Polo JM
    Curr Opin Genet Dev; 2017 Oct; 46():1-8. PubMed ID: 28646660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell fate conversion-from the viewpoint of small molecules and lineage specifiers.
    Zhao T; Li Y; Deng H
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():3-9. PubMed ID: 27615126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tox4 modulates cell fate reprogramming.
    Vanheer L; Song J; De Geest N; Janiszewski A; Talon I; Provenzano C; Oh T; Chappell J; Pasque V
    J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31519808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mevalonate Blockade in Cancer Cells Triggers CLEC9A
    Xu F; Wang Z; Zhang H; Chen J; Wang X; Cui L; Xie C; Li M; Wang F; Zhou P; Liu J; Huang P; Xia X; Xia X
    Cancer Res; 2021 Sep; 81(17):4514-4528. PubMed ID: 34266895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic transcription factors for cell fate reprogramming.
    Black JB; Gersbach CA
    Curr Opin Genet Dev; 2018 Oct; 52():13-21. PubMed ID: 29803990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy.
    Horton C; Davies TJ; Lahiri P; Sachamitr P; Fairchild PJ
    Stem Cells; 2020 Jan; 38(1):67-79. PubMed ID: 31621975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct reprogramming of mouse fibroblasts into cardiac myocytes.
    Inagawa K; Ieda M
    J Cardiovasc Transl Res; 2013 Feb; 6(1):37-45. PubMed ID: 23054660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.